Back
Verve Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
1
VERV
Verve Therapeutics
Last Price:
6.04
Seasonality Move:
-35.34%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Verve Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.83 | Buy |
| 20-day SMA: | 5.39 | Buy |
| 50-day SMA: | 5.39 | Buy |
| 200-day SMA: | 7.76 | Sell |
| 8-day EMA: | 5.79 | Buy |
| 20-day EMA: | 5.56 | Buy |
| 50-day EMA: | 5.49 | Buy |
| 200-day EMA: | 7.7 | Sell |
Verve Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 60.64 | Buy |
| Chaikin Money Flow: | 968401 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.77 - 5.79) | Buy |
| Bollinger Bands (100): | (4.8 - 6.44) | Buy |
Verve Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verve Therapeutics Stock
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 5.93 while VERV 8-day simple moving average is 5.83, which is a Buy signal.
- The stock price of VERV is 5.93 while Verve Therapeutics 20-day SMA is 5.39, which makes it a Buy.
- Verve Therapeutics 50-day simple moving average is 5.39 while VERV share price is 5.93, making it a Buy technically.
- VERV stock price is 5.93 and Verve Therapeutics 200-day simple moving average is 7.76, creating a Sell signal.
VERV Technical Analysis vs Fundamental Analysis
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy or a Sell?
-
Verve Therapeutics stock is rated a Sell
The current Verve Therapeutics [VERV] share price is $5.93. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Verve Therapeutics Stock Info
Market Cap:
501.82M
Price in USD:
5.93
Share Volume:
1.16M
Verve Therapeutics 52-Week Range
52-Week High:
20.12
52-Week Low:
4.31
Sell
1
Verve Therapeutics (VERV)
is a Sell
Verve Therapeutics Share Price Forecast
-
What is the Verve Therapeutics stock price today?
The Verve Therapeutics stock price is 5.93 USD today. -
Will VERV stock go up or go down?
Verve Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Verve Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verve Therapeutics is overvalued.
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 5.93 while VERV 8-day exponential moving average is 5.79, which is a Buy signal.
- The stock price of VERV is 5.93 while Verve Therapeutics 20-day EMA is 5.56, which makes it a Buy.
- Verve Therapeutics 50-day exponential moving average is 5.49 while VERV share price is 5.93, making it a Buy technically.
- VERV stock price is 5.93 and Verve Therapeutics 200-day simple moving average is 7.70, creating a Sell signal.
Fundamental Analysis of Verve Therapeutics
Is Verve Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
Technical Analysis of Verve Therapeutics
Should I short Verve Therapeutics stock?
- VERV Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Verve Therapeutics is a Buy
- Verve Therapeutics Relative Strength Index (RSI) is 60.64, which suggest Verve Therapeutics is overbought
- The Bollinger Bands (25) for Verve Therapeutics is (4.77 - 5.79), which suggest Verve Therapeutics is a Buy
- The Bollinger Bands (100) for Verve Therapeutics is (4.8 - 6.44), which suggest Verve Therapeutics is a Buy
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.